Efficacy of cutaneous steroid patch in keloids and hypertrophic scars

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

TCTR

Registry ID

TCTR20240707001

Enrollment

Registered

2024-07-07

Start date

2021-05-03

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

keloids and hypertrophic scars keloids, hypertrophic scars, cutaneous patch, steroid, randomized controlled trial

Interventions

cutaneous steroid patches containing Betamethasone 17,21 dipropionate,cutaneous patches without steroid

Active Comparator Device,Placebo Comparator Device

treatment group,placebo group

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1.Male/Female aged > 18 years old 2.Two or more keloids and hypertrophic scars 3.Willingness to participate

Exclusion criteria

Exclusion criteria: 1.Prior treatment with intralesional corticosteroid within 6 months 2.Dermatitis, Psoriasis, infection and other skin lesions at the site of lesion 3.On immunosuppressive drug 4.Corticosteroid allergy 5.Pregnancy and Lactation

Design outcomes

Primary

Measure	Time frame
Efficacy after treatment 6 months Patient and Observer Scar Assessment Scale (POSAS) score	—

Secondary

Measure	Time frame
Efficacy after treatment 6 months Vancouver Scar scale (VSS),volume 6 months Antera 3D camera,erythema index 6 months Antera 3D camera,melanin index 6 months Antera 3D camera,pliability 6 months Cutometer	—

Countries

Thailand

Contacts

Public Contactfaculty of medicine Srinakarinwirot university

Faculty of Medicine, Srinakhaeinwirot university

medicine@g.swu.ac.th073954515

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026